2023 Was a tough calendar year with the biopharma industry, with a number of companies downsizing and restructuring their workforces to remain afloat. You will discover signs of Restoration, as mergers and acquisitions picked up across the pharmaceutical and lifetime sciences market during the latter Section of 2023 and possess https://sites.google.com/view/bio-sites/blog